secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001619856-24-000071
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Jason O'Byrne resigns effective Sept 27; Ryan Fischesser named principal accounting officer
--------------------------------------------------------------------------------

- Jason O'Byrne resigns as CFO effective Sept 27, 2024, to pursue other opportunity; no disagreement with company.
- Company has initiated search for new CFO.
- Ryan Fischesser, VP Finance and Controller, will assume principal accounting officer role Sept 27.
- Fischesser previously served as principal accounting officer from IPO through Dec 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000071/0001619856-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000071/crbu-20240901.htm
  HTML page:      https://secwatch.observer/filing/0001619856-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer